Drug Target Insights, 1177-3928
Tidskrift
1 - 7 av 7Sidstorlek: 50
Expression of Luteinizing Hormone Receptor in the Gastrointestinal Tract in Patients with and without Dysmotility.
Oskar Hammar, Veress, B., Agneta Montgomery & Bodil Ohlsson, 2012, I : Drug Target Insights. 6, s. 13-18Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
Basal Plasma Levels of Copeptin are Elevated in Inactive Inflammatory Bowel Disease after Bowel Resection.
Bodil Ohlsson & Olle Melander, 2015, I : Drug Target Insights. 9, s. 21-27Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
New insights into the understanding of gastrointestinal dysmotility
Bodil Ohlsson & Sabina Janciauskiene, 2007, I : Drug Target Insights. 2, s. 229-237Forskningsoutput: Tidskriftsbidrag › Översiktsartikel
Antibodies against gonadotropin-releasing hormone in patients with posterior laryngitis.
Hillevi Pendleton, Alm, R., Nordin Fredrikson, G. & Bodil Ohlsson, 2013, I : Drug Target Insights. 7, Jan.,28, s. 1-8Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
Microscopic Colitis is Associated with Several Concomitant Diseases.
Roth, B., Jonas Manjer & Bodil Ohlsson, 2013, I : Drug Target Insights. 7, s. 19-25Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
Microscopic colitis and reproductive factors related to exposure to estrogens and progesterone.
Roth, B., Jonas Manjer & Bodil Ohlsson, 2013, I : Drug Target Insights. 7, Oct 7, s. 53-62Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift
The Expression of Serum Antibodies Against Gonadotropin-releasing Hormone (GnRH1), Progonadoliberin-2, Luteinizing Hormone (LH), and Related Receptors in Patients with Gastrointestinal Dysfunction or Diabetes Mellitus.
Roth, B., Kerstin Berntorp & Bodil Ohlsson, 2014, I : Drug Target Insights. 8, s. 45-50Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift